0001209191-23-024255.txt : 20230413
0001209191-23-024255.hdr.sgml : 20230413
20230413202140
ACCESSION NUMBER: 0001209191-23-024255
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230410
FILED AS OF DATE: 20230413
DATE AS OF CHANGE: 20230413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morris Shannon
CENTRAL INDEX KEY: 0001973527
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40602
FILM NUMBER: 23819489
MAIL ADDRESS:
STREET 1: C/O ERASCA, INC.
STREET 2: 3115 MERRYFIELD ROW, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Erasca, Inc.
CENTRAL INDEX KEY: 0001761918
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831217027
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 465-6511
MAIL ADDRESS:
STREET 1: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-04-10
0
0001761918
Erasca, Inc.
ERAS
0001973527
Morris Shannon
C/O ERASCA, INC.
3115 MERRYFIELD ROW, SUITE 300
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
7.91
2032-05-01
Common Stock
300000
D
Stock Option (Right to Buy)
4.00
2033-01-31
Common Stock
160800
D
25% of the shares subject to the options vest on May 2, 2023, the one-year anniversary of the vesting commencement date, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
1/48th of the shares subject to the option vest monthly following February 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
/s/ Shannon Morris
2023-04-13